Secura Bio, Inc. Email Format

Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees

Secura Bio, Inc. is a pharmaceutical manufacturing company based in Berkeley Heights, New Jersey, founded in 2019 to close the gap between innovative oncology therapies and patients who need them. It operates as an integrated pharmaceutical company focused on the development and commercialization of oncology medicines for hard-to-treat patient populations, drawing on decades of experience shaping major oncology clinical and market opportunities. The company has between 51 and 200 employees. In February 2026, Will Brown, formerly chief financial officer, was promoted to chief operating officer, while Chip Romp remains chief executive officer; Dr. Patrick Vink was named chairman of the board in June 2025. Secura Bio has engaged in industry events and investor activities, including participation in the 2025 American Society of Hematology Meeting and attendance at the 2026 Corporate Access event organized by the Gilmartin Group. Reported revenue is in the tens of millions of dollars range and the company has about $90 million in funding.

Sign up for free to view info

Company overview Employee directory